Quantitative PET of human urokinase-type plasminogen activator receptor with 64Cu-DOTA-AE105: implications for visualizing cancer invasion

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Expression levels of the urokinase-type plasminogen activator receptor (uPAR) represent an established biomarker for poor prognosis in a variety of human cancers. The objective of the present study was to explore whether noninvasive PET can be used to perform a quantitative assessment of expression levels of uPAR across different human cancer xenograft models in mice and to illustrate the clinical potential of uPAR PET in future settings for individualized therapy.
TidsskriftJournal of Nuclear Medicine
Udgave nummer1
Sider (fra-til)138-45
Antal sider8
StatusUdgivet - 2012

ID: 40215604